{"organizations": ["Amgen", "Novartis Can Sell Copycat of Amgen"], "uuid": "ddda03a0c561894351acd73963529d2c70e31b50", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "http://si.wsj.net/img/WSJ_Logo_black_social.gif", "site_section": "http://finance.yahoo.com/rss/headline?s=NVS", "section_title": "Yahoo! Finance: NVS News", "url": "http://www.wsj.com/articles/novartis-can-sell-copycat-of-amgens-neupogen-in-september-court-rules-1437503115?mod=yahoo_hs", "country": "US", "title": "Novartis Can Sell Copycat of Amgen's Neupogen in September", "performance_score": 0, "site": "wsj.com", "participants_count": 0, "title_full": "Novartis Can Sell Copycat of Amgen's Neupogen in September", "spam_score": 0.0, "site_type": "news", "published": "2015-07-21T21:25:00.000+03:00", "replies_count": 0, "uuid": "ddda03a0c561894351acd73963529d2c70e31b50"}, "author": "", "url": "http://www.wsj.com/articles/novartis-can-sell-copycat-of-amgens-neupogen-in-september-court-rules-1437503115?mod=yahoo_hs", "ord_in_thread": 0, "title": "Novartis Can Sell Copycat of Amgen's Neupogen in September", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Novartis Can Sell Copycat of Amgenâ€™s Neupogen in September, Court Rules Zarxio would be first knockoff of a biotech drug By Jonathan.Rockoff@wsj.com July 21, 2015 2:25 p.m. ET \nA U.S. appeals court ruled Tuesday that Novartis AG could begin selling the first knockoff of a biotech drug on Sept. 2, a key step in efforts to contain spending on high-cost therapies through lower-priced competition. \nThe ruling by the U.S. Court of Appeals for the Federal Circuit in Washington clears a way for Novartis to begin sales of Zarxio, a knockoff of cancer supportive-care drug Neupogen, which is sold by Amgen Inc. Yet... To Read the Full Story, Subscribe or Sign In Popular on WSJ", "external_links": [], "published": "2015-07-21T21:25:00.000+03:00", "crawled": "2015-07-21T21:56:20.923+03:00", "highlightTitle": ""}